Agarikon (Fomitopsis officinalis)

Fomitopsis officinalis — known as Agarikon or Quinine Conk — is a large, long-lived polypore mushroom that grows on old-growth conifers in the Pacific Northwest of North America and parts of Europe. Individual
specimens can live for decades — with some documented growths reaching over 75 years old.

Agarikon holds the distinction of being one of the oldest documented medicinal mushrooms in Western history — referenced by the Greek physician Dioscorides around 65 AD in his influential pharmacological text De Materia Medica, where he recommended it for tuberculosis, infectious coughs, and other serious illnesses.

Today Agarikon is critically endangered in its native European habitat and rare in the Pacific Northwest —
making cultivated mycelium extracts the only sustainable source for supplemental use. The Paul Stamets laboratory has been at the forefront of researching Agarikon's potential antiviral properties with funding from the United States government.

Agarikon's bioactive compounds include unique molecules not found in other mushrooms:

- Agaric Acid and Related Triterpenoids — unique lanostane-type triterpenes that have demonstrated
antimicrobial and anti-inflammatory activity in laboratory research

- Antiviral Polysaccharides — research funded by the Defense Advanced Research Projects Agency (DARPA) found Agarikon extracts showed significant activity against multiple viral strains including influenza and poxviruses in laboratory models

- Beta-Glucans — activate innate immune responses through established pattern recognition receptor pathways

- Quinones — antimicrobial compounds that may contribute to Agarikon's historical use for infectious conditions

Agarikon has limited but generally positive safety data:

- Limited human clinical safety data compared to more commonly used mushrooms — used safely
in traditional contexts for centuries
- Well tolerated in available research
- Those with autoimmune conditions should consult a doctor
- May interact with immunosuppressant medications
- Not recommended during pregnancy or nursing without medical supervision
- As a rare mushroom, ensure sourcing from reputable suppliers with quality verification

- Stamets et al. (2011) — Research funded by the US Department of Defense and published in PLOS ONE
found Agarikon extracts showed significant antiviral activity against H1N1, H3N2, H5N1 influenza strains and smallpox viruses in laboratory models — generating substantial interest from national biosecurity agencies.

- Zjawiony (2004) — Review in the Journal of Natural Products documented Fomitopsis officinalis' bioactive compound profile and its historical medicinal applications across European traditions.

- Lindequist et al. (2005) — Review in Evidence-Based Complementary and Alternative Medicine established the pharmacological properties of rare polypore mushrooms including Fomitopsis species.